{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:05:53Z","timestamp":1770991553524,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1007\/s11908-000-0024-x","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T02:55:54Z","timestamp":1180061754000},"page":"121-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Current and future use of vaccines for viral and bacterial respiratory tract infections"],"prefix":"10.1007","volume":"2","author":[{"given":"Martin G.","family":"Ottolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"24_CR1","unstructured":"Lambert PH: The future of vaccines. Presented at 37th Meeting of the Infectious Disease Society of America. Philadelphia, 1999."},{"key":"24_CR2","unstructured":"World Health Organization: Infectious Disease Report: WWW.WHO.INT\/INFECTIOUS-DISEASE-REPORT; 1999."},{"key":"24_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1542\/peds.105.1.148","volume":"105","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2000","unstructured":"American Academy of Pediatrics Committee on Infectious Diseases: Childhood immunization schedule. Pediatrics 2000, 105:148\u2013151.","journal-title":"Pediatrics"},{"key":"24_CR4","series-title":"Report of the Committee on Infectious Diseases: influenza","first-page":"307","volume-title":"1997 Red Book","year":"1997","unstructured":"Report of the Committee on Infectious Diseases: influenza. In 1997 Red Book, edn 24. Edited by Peter G. Elk Grove Village, IL: American Academy of Pediatrics; 1997:307\u2013315.","edition":"edn 24"},{"key":"24_CR5","series-title":"Report of the Committee on Infectious Diseases: pneumococcal infections","first-page":"410","volume-title":"1997 Red Book","year":"1997","unstructured":"Peter G (ed): Report of the Committee on Infectious Diseases: pneumococcal infections. In 1997 Red Book, edn 24. Elk Grove Village, IL: American Academy of Pediatrics; 1997: 410\u2013419.","edition":"edn 24"},{"key":"24_CR6","first-page":"327","volume":"44","author":"BG Gellin","year":"1999","unstructured":"Gellin BG, Curlin GT, Rabinovich NR, LaMontagne JR: Adult immunization principles and practice. Adv Intern Med 1999, 44:327\u2013352.","journal-title":"Adv Intern Med"},{"key":"24_CR7","series-title":"Report of the Committee on Infectious Diseases: meningococcal infections","first-page":"357","volume-title":"1997 Red Book","year":"1997","unstructured":"Report of the Committee on Infectious Diseases: meningococcal infections. In 1997 Red Book, edn 24. Edited by Peter G. Elk Grove Village, IL: American Academy of Pediatrics; 1997:357\u2013362.","edition":"edn 24"},{"key":"24_CR8","first-page":"1","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","unstructured":"Centers for Disease Control and Prevention: The role of BCG vaccine in the prevention and control of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 1996, 45:1\u201318.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0891-5520(05)70039-8","volume":"13","author":"DR Lucey","year":"1999","unstructured":"Lucey DR: Evolution of the type-1 (Th1)-type-2 (Th2) cytokine paradigm. Infect Dis Clin North Am 1999, 13:1\u20139. A nice review of the Th1 and Th2 paradigm, with a simple and very lucid discussion focusing on vaccine development.","journal-title":"Infect Dis Clin North Am"},{"key":"24_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0891-5520(05)70046-5","volume":"13","author":"H Ahmad","year":"1999","unstructured":"Ahmad H, Chapnick EK: Conjugated polysaccharide vaccines. Infect Dis Clin North Am 1999, 13:113\u2013133. A straightforward and simple discussion of protein conjugate vaccine technology in relation to three of the most important bacterial pathogens: Hib, pneumococcus, and meningococcus.","journal-title":"Infect Dis Clin North Am"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0095-5108(18)30194-5","volume":"24","author":"GW Fischer","year":"1997","unstructured":"Fischer GW, Ottolini MG, Mond JJ: Prospects for vaccines during pregnancy and in the newborn period. Clin Perinatol 1997, 24:231\u2013249.","journal-title":"Clin Perinatol"},{"key":"24_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0891-5520(05)70040-4","volume":"13","author":"JR Haynes","year":"1999","unstructured":"Haynes JR: Genetic vaccines. Infect Dis Clin North Am 1999, 13:11\u201325. A simple and very readable discussion of an often esoteric subject that contains both a review of practical physical issues regarding DNA vaccines and a thorough discussion of several immunologic manipulations that have been attempted with this technology.","journal-title":"Infect Dis Clin North Am"},{"key":"24_CR13","first-page":"1142","volume-title":"Textbook of Pediatric Infectious Diseases","author":"PA Mendelman","year":"1987","unstructured":"Mendelman PA, Smith AL: Haemophilus influenzae. In Textbook of Pediatric Infectious Diseases. Edited by Feigin R, Cherry J. Philadelphia: WB Saunders; 1987:1142\u20131163."},{"key":"24_CR14","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1097\/00006454-199809001-00004","volume":"17","author":"MD Decker","year":"1998","unstructured":"Decker MD, Edwards KM: Haemophilus influenzae type B vaccines: history, choice, and comparisons. Pediatr Infect Dis J 1998, 17:S113-S116.","journal-title":"Pediatr Infect Dis J"},{"key":"24_CR15","first-page":"279","volume":"13","author":"TV Murphy","year":"1998","unstructured":"Murphy TV: Haemophilus influenzae vaccines: 1997. Adv Pediatr Infect Dis 1998, 13:279\u2013304.","journal-title":"Adv Pediatr Infect Dis"},{"key":"24_CR16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1086\/515119","volume":"28","author":"JM Kyd","year":"1999","unstructured":"Kyd JM, Cripps AW: Towards a protein vaccine for nontypeable Haemophilus influenzae. Clin Infect Dis 1999, 28:238.","journal-title":"Clin Infect Dis"},{"key":"24_CR17","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/S0140-6736(99)04377-9","volume":"354","author":"J Eskola","year":"1999","unstructured":"Eskola J, Ward J, Dagan R, et al.: Combined vaccination of Haemophilus influenzae type B conjugate and diptheriatetanus-pertussis containing acellular pertussis. Lancet 1999, 354:2063\u20132068.","journal-title":"Lancet"},{"key":"24_CR18","first-page":"2414","volume-title":"Principles and Practices of Infectious Diseases","author":"EL Hewlett","year":"2000","unstructured":"Hewlett EL: Bordetella species. In Principles and Practices of Infectious Diseases. Edited by Mandell GL, Bennett JE, Dolin R. Philadelphia: Churchill Livingstone; 2000:2414\u20132421."},{"key":"24_CR19","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1542\/peds.104.6.1381","volume":"104","author":"JD Cherry","year":"1999","unstructured":"Cherry JD, Olin P: The science and fiction of pertussis vaccines. Pediatrics 1999, 104:1381\u20131384. A brief but outstanding discussion of acellular pertussis vaccines.","journal-title":"Pediatrics"},{"key":"24_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0891-5520(05)70044-1","volume":"13","author":"WA Keitel","year":"1999","unstructured":"Keitel WA, Edwards KM: Acellular pertussis vaccines in adults. Infect Dis Clin North Am 1999, 13:83\u201394.","journal-title":"Infect Dis Clin North Am"},{"key":"24_CR21","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/jama.202.12.1075","volume":"202","author":"VA Fulginetti","year":"1967","unstructured":"Fulginetti VA, Eller JJ, Downie AW, Kempe CH: Altered reactivity to measles virus: atypical measles in children previously immunized with inactivated measles virus vaccine. JAMA 1967, 202:1075\u20131080.","journal-title":"JAMA"},{"key":"24_CR22","first-page":"1801","volume-title":"Principles and Practices of Infectious Diseases","author":"AA Gershon","year":"2000","unstructured":"Gershon AA: Measles. In Principles and Practices of Infectious Diseases. Edited by Mandell GL, Bennett JE, Dolin R. Philadelphia: Churchill Livingstone; 2000:1801\u20131809."},{"key":"24_CR23","first-page":"749","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","unstructured":"Centers for Disease Control and Prevention: Epidemiology of measles: United States, 1998. MMWR Morb Mortal Wkly Rep 1999, 48:749\u2013753.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"24_CR24","first-page":"389","volume":"50","author":"World Health Organization","year":"1998","unstructured":"World Health Organization: Measles: progress towards global control and regional elimination, 1990\u20131998. Wkly Epidemiol Rec 1998, 50:389\u2013394.","journal-title":"Wkly Epidemiol Rec"},{"key":"24_CR25","unstructured":"Ambrosia D: Conjugate pneumococcal vaccines. Presented at 37th Meeting of the Infectious Disease Society of America. Philadelphia, 1999."},{"key":"24_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1542\/peds.101.4.604","volume":"101","author":"MB Rennels","year":"1998","unstructured":"Rennels MB, Edwards KM, Keyserling HL, et al.: Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in the United States. Pediatrics 1998, 101:604\u2013611.","journal-title":"Pediatrics"},{"key":"24_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0022-3476(96)80130-2","volume":"128","author":"EL Anderson","year":"1996","unstructured":"Anderson EL, Kennedy DJ, Geldmacher KM, et al.: Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 1996, 128:649\u2013653.","journal-title":"J Pediatr"},{"key":"24_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00006454-199906000-00015","volume":"18","author":"J Eskola","year":"1999","unstructured":"Eskola J, Anttila M: Pneumococcal conjugate vaccines. Pediatr Infect Dis J 1999, 18:543\u2013551.","journal-title":"Pediatr Infect Dis J"},{"key":"24_CR29","first-page":"379","volume-title":"Abstracts of the 1999 Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"S Black","year":"1999","unstructured":"Black S, Shinefield, Ray P: Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: impact on pneumonia, otitis media, and an update on invasive disease-results of the Northern California Kaiser Permanente efficacy trial. In Abstracts of the 1999 Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco: American Society of Microbiology; 1999:379. A large, well-designed study demonstrating the exciting efficacy of the next generation of conjugate pneumococcal vaccines."},{"key":"24_CR30","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","volume":"174","author":"R Dagan","year":"1996","unstructured":"Dagan R, Meiamed R, Muallem M, et al.: Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate vaccine. J Infect Dis 1996, 174:1271\u20131278.","journal-title":"J Infect Dis"},{"key":"24_CR31","first-page":"1","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","unstructured":"Centers for Disease Control and Prevention: Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. MMWR Morb Mortal Wkly Rep 1999, 48:1\u201313.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"24_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0891-5520(05)70049-0","volume":"13","author":"IM Orme","year":"1999","unstructured":"Orme IM: New vaccines against tuberculosis. Infect Dis Clin North Am 1999, 13:169\u2013186.","journal-title":"Infect Dis Clin North Am"},{"key":"24_CR33","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.271.9.698","volume":"271","author":"GA Colditz","year":"1994","unstructured":"Colditz GA, Brewer TF, Berkey CS, et al.: Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA 1994, 271:698\u2013702.","journal-title":"JAMA"},{"key":"24_CR34","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nm0896-888","volume":"2","author":"RE Tascon","year":"1996","unstructured":"Tascon RE, Colston MJ, Stavropoulos E, et al.: Immunization against tuberculosis by a DNA vaccine. Nat Med 1996, 2:888\u2013892.","journal-title":"Nat Med"},{"key":"24_CR35","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nm0896-893","volume":"2","author":"K Huygen","year":"1996","unstructured":"Huygen K, Content J, Denis O, et al.: Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 1996, 2:893\u2013898.","journal-title":"Nat Med"},{"key":"24_CR36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","volume":"89","author":"AZ Kapikian","year":"1969","unstructured":"Kapikian, AZ, Mitchell RH, Chanock R, et al.: An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously immunized with an inactivated RS virus vaccine. Am J Epidemiol 1969, 89:405\u2013421.","journal-title":"Am J Epidemiol"},{"key":"24_CR37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.11.3.430","volume":"11","author":"RA Dudas","year":"1999","unstructured":"Dudas RA, Karron RA: Respiratory syncytial virus vaccines. Clin Microbiol Rev 1999, 11:430\u2013439. A thorough, well-detailed, and readable analysis of nearly 40 years of RSV vaccine development; particularly for those not familiar with this field.","journal-title":"Clin Microbiol Rev"},{"key":"24_CR38","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0264-410X(90)90253-I","volume":"8","author":"BR Murphy","year":"1990","unstructured":"Murphy BR, Sotnikov AV, Lawrence LA, et al.: Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine 1990, 8:497\u2013502.","journal-title":"Vaccine"},{"key":"24_CR39","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2165\/00003495-199754060-00006","volume":"54","author":"MG Ottolini","year":"1997","unstructured":"Ottolini MG, Hemming VG: Prevention and treatment recommendations for respiratory syncytial virus infection. Drugs 1997, 54:867\u2013884.","journal-title":"Drugs"},{"key":"24_CR40","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","volume":"163","author":"CB Hall","year":"1991","unstructured":"Hall CB, Walsh EE, Long CE, Scnabel KC: Immunity to and reinfection with respiratory syncytial virus. J Infect Dis 1991, 163:693\u2013698.","journal-title":"J Infect Dis"},{"key":"24_CR41","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1086\/514138","volume":"176","author":"RA Karron","year":"1997","unstructured":"Karron RA, Wright PF, Crowe JE, et al.: Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis 1997, 176:1428\u20131436.","journal-title":"J Infect Dis"},{"key":"24_CR42","unstructured":"Wright PF: Live attenuated RSV vaccines. Presented at RSV After 43 Years. Stuart, FL, 1999."},{"key":"24_CR43","first-page":"333","volume":"13","author":"SE Coffin","year":"1998","unstructured":"Coffin SE, Offit PA: New vaccines against mucosal pathogens. Adv Pediatr Infect Dis 1998, 13:333\u2013348.","journal-title":"Adv Pediatr Infect Dis"},{"key":"24_CR44","first-page":"1","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","unstructured":"Centers for Disease Control and Prevention: Prevention and control of influenza. MMWR Morb Mortal Wkly Rep 1999, 48:1\u201323.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"24_CR45","first-page":"125","volume":"10","author":"K Ryan-Porter","year":"1995","unstructured":"Ryan-Porter K: Influenza virus infection in children. Adv Pediatr Infect Dis 1995, 10:125\u2013156.","journal-title":"Adv Pediatr Infect Dis"},{"key":"24_CR46","doi-asserted-by":"crossref","unstructured":"Influenza vaccine. Med Lett 1999, 41:82\u201383.","DOI":"10.1080\/00401706.1999.10485615"},{"key":"24_CR47","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1542\/peds.103.6.e73","volume":"103","author":"T White","year":"1999","unstructured":"White T, Lavoie S, Nettleman MD: Potential cost savings attributable to influenza vaccination of school-aged children. Pediatrics 1999, 103:e73.","journal-title":"Pediatrics"},{"key":"24_CR48","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.4049\/jimmunol.102.3.728","volume":"102","author":"HF Maassab","year":"1969","unstructured":"Maassab HF: Biologic and immunologic characteristics of cold-adapted influenza virus. J Immunol 1969, 102:7228\u20137232.","journal-title":"J Immunol"},{"key":"24_CR49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/infdis\/169.1.68","volume":"169","author":"KM Edwards","year":"1994","unstructured":"Edwards KM, Dupont WD, Westrich MK, et al.: A randomized controlled trial of intranasal drop administration of coldadapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994, 169:68\u201376.","journal-title":"J Infect Dis"},{"key":"24_CR50","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","volume":"338","author":"RB Belshe","year":"1998","unstructured":"Belshe RB, Mendelman PM, Treanor J, et al.: The efficacy of live attenuated cold-adapted intranasal influenzavirus vaccine in children. N Engl J Med 1998, 338:1405\u20131412.","journal-title":"N Engl J Med"},{"key":"24_CR51","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0264-410X(94)80056-6","volume":"12","author":"H Kuno-Sakai","year":"1994","unstructured":"Kuno-Sakai H, Kimura M, Ohta K, et al.: Development in mucosal influenza virus vaccines. Vaccine 1994, 12:1303\u20131310.","journal-title":"Vaccine"},{"key":"24_CR52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0891-5520(05)70052-0","volume":"13","author":"JB Dale","year":"1999","unstructured":"Dale JB: Group A streptococcal vaccines. Infect Dis Clin North Am 1999, 13:227\u2013243.","journal-title":"Infect Dis Clin North Am"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-000-0024-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-000-0024-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-000-0024-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-000-0024-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:32:23Z","timestamp":1744165943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-000-0024-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1007\/s11908-000-0024-x","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}